Provided by Tiger Trade Technology Pte. Ltd.

Werewolf Therapeutics, Inc.

0.7931
+0.00710.90%
Volume:64.37K
Turnover:51.45K
Market Cap:38.50M
PE:-0.49
High:0.8000
Open:0.7900
Low:0.7900
Close:0.7860
52wk High:2.38
52wk Low:0.5301
Shares:48.54M
Float Shares:35.00M
Volume Ratio:1.87
T/O Rate:0.18%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6177
EPS(LYR):-1.6273
ROE:-122.43%
ROA:-40.75%
PB:1.30
PE(LYR):-0.49

Loading ...

Werewolf Therapeutics Files Initial Beneficial Ownership Statement for Michael J. Urban, VP of Finance & Corporate Controller

Reuters
·
Mar 14

U.S. Earnings Preview: Before Market Open March 10

Dow Jones
·
Mar 10

Werewolf Therapeutics Inc expected to post a loss of 35 cents a share - Earnings Preview

Reuters
·
Feb 27

Werewolf Therapeutics to Explore Strategic Alternatives, Including Potential Sale, Merger, Asset Sale, or Licensing Deals, to Maximize Stockholder Value

Reuters
·
Feb 25

Werewolf Therapeutics trading halted, news pending

TIPRANKS
·
Feb 25

NASDAQ TRADE HALT HALT NEWS PENDING AT 04:10 PM

Reuters
·
Feb 25

Werewolf Therapeutics Inc - Options Include Sale, Merger, Asset Sale, Licensing

THOMSON REUTERS
·
Feb 25

Werewolf Therapeutics announces 64% workforce reduction

TIPRANKS
·
Feb 14

Werewolf Therapeutics Inc - to Reduce Workforce by 64% - SEC Filing

THOMSON REUTERS
·
Feb 14

Werewolf Therapeutics Cuts 64% of Workforce in Major Reorganization

Reuters
·
Feb 14

Werewolf Therapeutics Receives Nasdaq Minimum Bid Price Notice

TIPRANKS
·
Feb 07

Werewolf Therapeutics Faces Nasdaq Delisting Risk Over Minimum Bid Price Compliance

Reuters
·
Feb 07

Director Luke Evnin Reports Sale of Werewolf Therapeutics Common Shares

Reuters
·
Jan 21

Director Luke Evnin Reports Disposal of Werewolf Therapeutics Inc. Common Shares

Reuters
·
Jan 16

Director Luke Evnin Reports Disposal of Werewolf Therapeutics Inc. Common Shares

Reuters
·
Jan 13

Director Luke Evnin Reports Disposal of Werewolf Therapeutics Inc. Common Shares

Reuters
·
Jan 08

Director Luke Evnin Reports Disposal of Werewolf Therapeutics Inc. Common Shares

Reuters
·
Jan 03

Director Luke Evnin Reports Disposal of Werewolf Therapeutics Inc. Common Shares

Reuters
·
Dec 30, 2025

Wedbush Downgrades Werewolf Therapeutics to Neutral From Outperform Due to 'Forward Challenging' Path, Cuts Price Target to $1 From $3

MT Newswires Live
·
Dec 19, 2025

Werewolf Therapeutics Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Dec 19, 2025